14-day Premium Trial Subscription Sign Up For FreeGet Free

Denali Therapeutics Inc. Stock Forecast NASDAQ:DNLI

$32.36 (-1.46%)

Volume: 649k

Closed: Jan 21, 2022

Hollow Logo Score: -4.236

Denali Therapeutics Inc. Stock Forecast

$32.36 (-1.46%)

Volume: 649k

Closed: Jan 21, 2022

Score Hollow Logo -4.236
Which way will DNLI go? Request
Key Stats
P/E Ratio 135.65
Beta 1.36
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 26 and the stock is currently not being overbought or oversold

Denali Therapeutics Inc. stock price ended on $32.36 on Friday after losing 1.46%
(Updated on Jan 21, 2022)

Sell candidate since 2022-01-04 Loss -29.16% PDF

The Denali Therapeutics Inc. stock price fell by -1.46% on the last day (Friday, 21st Jan 2022) from $32.84 to $32.36. and has now fallen 3 days in a row. During the day the stock fluctuated 6.79% from a day low at $32.24 to a day high of $34.43. The price has fallen in 7 of the last 10 days and is down by -26.39% for this period. Volume has increased on the last day by 172 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 649 thousand shares were bought and sold for approximately $21.02 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $30.75 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -23.86% during the next 3 months and, with a 90% probability hold a price between $23.41 and $33.77 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, January 18, 2022, and so far it has risen 2.99%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Denali Therapeutics Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $33.86 and $42.48. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

Denali Therapeutics Inc. finds support from accumulated volume at $31.42 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.19 between high and low, or 6.79%. For the last week, the stock has had a daily average volatility of 7.54%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Denali Therapeutics Inc. stock A Buy?

Denali Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.236

Sell Candidate Unchanged

Insiders are positive buying more shares than they are selling in Denali Therapeutics Inc.

In the last 100 trades there were 872.25 thousand shares bought and 750.6 thousand shares sold. The last trade was done 14 days ago by Thornberry Nancy who bough 627 shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside. In some cases larger purchases can be explained by due date for stock options.

Predicted Opening Price for Denali Therapeutics Inc. of Monday, January 24, 2022

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price January 24, 2022 Current price
$33.01 $32.36 (Undervalued)

Remember To Visit Our YouTube Channel

Analyst Ratings

On Jan 06, 2022 "Morgan Stanley" gave "$99.00 - $91.00" rating for DNLI. The price target was changed from $43.96 to 1.3%.

Volatility and Risk
Daily Average Volatility: 7.54 %
Overall Risk: Very High High Medium Low Very Low
7.54 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $33.17
Price: $32.36
Support: $31.42

DNLI Insider Trading Show all Trades



Last 100 transactions
Buy: 872 252 | Sell: 750 597 (Shares)
Date Action Amount Person Type
Jan 08, 2022 Buy 627 Thornberry Nancy Common Stock
Jan 05, 2022 Sell 2 846 Schuth Alexander O. Common Stock
Jan 05, 2022 Sell 2 845 Ho Carole Common Stock
Jan 05, 2022 Sell 2 225 Krognes Steve E. Common Stock
Jan 05, 2022 Sell 5 007 Watts Ryan J. Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 872 252 | Sell: 750 597 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 35.20 8.78 %
34.36 6.19 %
33.85 4.59 %
Current price: 32.36
Support 32.17 -0.58 %
31.66 -2.17 %
30.82 -4.76 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 34.84 7.66 %
33.86 4.64 %
33.17 2.50 %
Current price 32.36
Support 31.42 -2.90%
0 .
0 .

Click to get the best stock tips daily for free!

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE